Russian Health Minister Mikhail Murashko has announced the end of clinical trials at the Gamali vaccine center against the Covid-19 virus.
The Russian minister pointed out in a press conference that “clinical tests were completed on a vaccine against Coronavirus infection, which was developed by the “Gamaleya National Center for Epidemiology and Microbiology Research”, and the necessary documents are being prepared to officially register the vaccine”.
According to the Russian minister, this vaccine will be used, after registration, to vaccinate primarily medical and school workers.
Murashko confirmed that the commercial production of the vaccine will begin next October.
The Russian minister revealed that the government center is currently working on developing another vaccine against the Coronavirus, and entered the stages of clinical trials.
Clinical trials are a scientific term referring to human vaccine testing.
Russia had previously announced that it would be the first vaccine to obtain international approval, after testing had ended.
Russia is not alone in developing vaccines for Coronavirus, as more than 150 vaccines around the world are currently being developed and tested, but it has not received widespread approval to use them yet.
On Saturday, Russia recorded 95 new deaths, raising the death toll in the country to more than 14,000.
On the same day, the country recorded more than 5,400 cases in the last 24 hours, bringing the total number of cases to more than 845,000.